PharmAust engages Canadian-based specialists to reformulate monepantel
170627_PharmAust engages Canadian-based specialists to reformulate monepantel
PharmAust secures broad European patent for non-cancer applications
170608_PharmAust secures broad European patent for non-cancer applications
PharmAust secures core patent in Japan
170606_PharmAust secures core patent in Japan
PharmAust Shareholders Update and Roadmap
170530_PharmAust Shareholders Update and Roadmap
Phase II dog lymphoma trial preliminary results demonstrate Monepantel clinical benefit
170519_Phase II dog lymphoma trial preliminary results demonstrate Monepantel clinical benefit
PharmAust secures broad patent coverage for non-cancer applications
170517_PharmAust secures broad patent coverage for non-cancer applications